Fine‐needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities von VanderLaan, Paul A.

Volltext

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma von Rangachari, Deepa, VanderLaan, Paul A., Shea, Meghan, Le, Xiuning, Huberman, Mark S., Kobayashi, Susumu S., Costa, Daniel B.

Volltext

EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical... von Rangachari, Deepa, To, Ciric, Shpilsky, Jason E., VanderLaan, Paul A., Kobayashi, Susumu S., Mushajiang, Mierzhati, Lau, Christie J., Paweletz, Cloud P., Oxnard, Geoffrey R., Jänne, Pasi A., Costa, Daniel B.

Volltext

Molecular markers: Implications for cytopathology and specimen collection von VanderLaan, Paul A.

Volltext

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer von Bahcall, Magda, Awad, Mark M, Sholl, Lynette M, Wilson, Frederick H, Xu, Man, Wang, Stephen, Palakurthi, Sangeetha, Choi, Jihyun, Ivanova, Elena V, Leonardi, Giulia C, Ulrich, Bryan C, Paweletz, Cloud P, Kirschmeier, Paul T, Watanabe, Masayuki, Baba, Hideo, Nishino, Mizuki, Nagy, Rebecca J, Lanman, Richard B, Capelletti, Marzia, Chambers, Emily S, Redig, Amanda J, VanderLaan, Paul A, Costa, Daniel B, Imamura, Yu, Jänne, Pasi A

Volltext

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT von de Margerie-Mellon, Constance, Ngo, Long H, Gill, Ritu R, Monteiro Filho, Antonio C, Heidinger, Benedikt H, Onken, Allison, Medina, Mayra A, VanderLaan, Paul A, Bankier, Alexander A

Volltext

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized? von Sehgal, Kartik, Varkaris, Andreas, Viray, Hollis, VanderLaan, Paul A, Rangachari, Deepa, Costa, Daniel B

Volltext

Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: a single center analy... von DiStasio, Marcello, MD, PhD, Chen, Yigu, MPH, Rangachari, Deepa, MD, Costa, Daniel B., MD, PhD, Heher, Yael K., MD, MPH, VanderLaan, Paul A., MD, PhD

Volltext

Percutaneous Lung Biopsy: Point-Fine-Needle Aspiration First von VanderLaan, Paul A

Volltext

Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology von Layfield, Lester J., Roy-Chowdhuri, Sinchita, Baloch, Zubair, Ehya, Hormoz, Geisinger, Kim, Hsiao, Susan J., Lin, Oscar, Lindeman, Neal I., Roh, Michael, Schmitt, Fernando, Sidiropoulos, Nikoletta, VanderLaan, Paul A.

Volltext

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors von Vasconcelos, Pedro E.N.S., Gergis, Carol, Viray, Hollis, Varkaris, Andreas, Fujii, Masanori, Rangachari, Deepa, VanderLaan, Paul A., Kobayashi, Ikei S., Kobayashi, Susumu S., Costa, Daniel B.

Volltext

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio von Krane, Jeffrey F., VanderLaan, Paul A., Faquin, William C., Renshaw, Andrew A.

Volltext

The 2023 Bethesda System for Reporting Thyroid Cytopathology von Ali, Syed Z, Baloch, Zubair W, Cochand-Priollet, Beatrix, Schmitt, Fernando C, Vielh, Philippe, VanderLaan, Paul A

Volltext

Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice von VanderLaan, Paul A, Reardon, Catherine A, Cabana, Veneracion G, Wang, Chyung-Ru, Getz, Godfrey S

Volltext

EGFR testing in advanced non-small-cell lung cancer, a mini-review von Sheikine, Yuri, MD, PhD, Rangachari, Deepa, MD, McDonald, Danielle C., NP, Huberman, Mark S., MD, Folch, Erik S., MD, MSc, VanderLaan, Paul A., MD, PhD, Costa, Daniel B., MD, PhD

Volltext

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer von Sehgal, Kartik, Peters, Mary Linton B., VanderLaan, Paul A., Rangachari, Deepa, Kobayashi, Susumu S., Costa, Daniel B.

Volltext

Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer von Folch, Erik, Yamaguchi, Norihiro, VanderLaan, Paul A., Kocher, Olivier N., Boucher, David H., Goldstein, Michael A., Huberman, Mark S., Kent, Michael S., Gangadharan, Sidharta P., Costa, Daniel B., Majid, Adnan

Volltext

Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens von Medina, Mayra A., Onken, Allison M., Margerie‐Mellon, Constance, Heidinger, Benedikt H., Chen, Yigu, Bankier, Alexander A., VanderLaan, Paul A.

Volltext

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors von Le, Xiuning, Desai, Neelam V, Majid, Adnan, Karp, Rebecca S, Huberman, Mark S, Rangachari, Deepa, Kent, Michael S, Gangadharan, Sidharta P, Folch, Erik, VanderLaan, Paul A, Costa, Daniel B

Volltext

Atypia of Undetermined Significance and Nondiagnostic Rates in The Bethesda System for Reporting Thyroid Cytopathology Are Inversely Related von VANDERLAAN, Paul A, RENSHAW, Andrew A, KRANE, Jeffrey F

Volltext